Characterization of the interactions of chemically-modified therapeutic nucleic acids with plasma proteins using a fluorescence polarization assay

Hans Gaus(Ionis Pharmaceuticals (United States)), Punit P. Seth(Ionis Pharmaceuticals (United States)), Eric E. Swayze(Ionis Pharmaceuticals (United States)), Michael E. Østergaard(Ionis Pharmaceuticals (United States)), Alfred E. Chappell(Ionis Pharmaceuticals (United States)), Ruchi Gupta(Ionis Pharmaceuticals (United States))
Nucleic Acids Research
December 13, 2018
10.1093/nar/gky1260
Cited by 141

Related Papers

Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary<i>N</i>-acetyl galactosamine improves potency 10-fold in mice
|Nucleic Acids Research|2014|594
Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals
|Nucleic Acids Research|2006|461
Pyrene-functionalized oligonucleotides and locked nucleic acids (LNAs): Tools for fundamental research, diagnostics, and nanotechnology
|Chemical Society Reviews|2011|256
Stabilin-1 and Stabilin-2 are specific receptors for the cellular internalization of phosphorothioate-modified antisense oligonucleotides (ASOs) in the liver
|Nucleic Acids Research|2016|163
Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNS
|Nucleic Acids Research|2013|162